Citation: Jm. Lusher et al., Dopamine D4 receptor gene (DRD4) is associated with Novelty Seeking (NS) and substance abuse: the saga continues ..., MOL PSYCHI, 6(5), 2001, pp. 497-499
Authors:
White, GC
Rosendaal, F
Aledort, LM
Lusher, JM
Rothschild, C
Ingerslev, J
Citation: Gc. White et al., Definitions in hemophilia - Recommendation of the Scientific Subcommittee on factor VIII and factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, THROMB HAEM, 85(3), 2001, pp. 560-560
Citation: A. Unuvar et al., Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors, HAEMOPHILIA, 6(3), 2000, pp. 150-157
Authors:
Ragni, MV
Lusher, JM
Koerper, MA
Manco-Johnson, M
Krause, DS
Citation: Mv. Ragni et al., Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia, HAEMOPHILIA, 6(2), 2000, pp. 98-103
Citation: Jm. Lusher, Acute hemarthroses: the benefits of early versus late treatment with recombinant activated factor VII, BL COAG FIB, 11, 2000, pp. S45-S49
Authors:
Kulkarni, R
Lusher, JM
Henry, RC
Kallen, DJ
Citation: R. Kulkarni et al., Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council, HAEMOPHILIA, 5(6), 1999, pp. 410-415
Authors:
Thorland, EC
Drost, JB
Lusher, JM
Warrier, I
Shapiro, A
Koerper, MA
Dimichele, D
Westman, J
Key, NS
Sommer, SS
Citation: Ec. Thorland et al., Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk, HAEMOPHILIA, 5(2), 1999, pp. 101-105
Authors:
Seremetis, S
Lusher, JM
Abildgaard, CF
Kasper, CK
Allred, R
Hurst, D
Citation: S. Seremetis et al., Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy, HAEMOPHILIA, 5(1), 1999, pp. 9-16
Citation: R. Kulkarni et Jm. Lusher, Intracranial and extracranial hemorrhages in newborns with hemophilia: A review of the literature, J PED H ONC, 21(4), 1999, pp. 289-295
Citation: Jm. Lusher, Gene therapy for hemophilia A and B: Patient selection and follow-up, requirements for a cure, THROMB HAEM, 82(2), 1999, pp. 572-575
Citation: Jm. Lusher, Inhibitor development in prospective clinical trials with recombinant factor VIII preparations in previously untreated patients, VOX SANGUIN, 77, 1999, pp. 9-9
Authors:
Lusher, JM
Roberts, HR
Davignon, G
Joist, JH
Smith, H
Shapiro, A
Laurian, Y
Kasper, CK
Mannucci, PM
Citation: Jm. Lusher et al., A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors, HAEMOPHILIA, 4(6), 1998, pp. 790-798
Citation: Jm. Lusher, Clinical guidelines for treating von Willebrand disease patients who are not candidates for DDAVP - a survey of European physicians, HAEMOPHILIA, 4, 1998, pp. 11-14
Authors:
Key, NS
Aledort, LM
Beardsley, D
Cooper, HA
Davignon, G
Ewenstein, BM
Gilchrist, GS
Gill, JC
Glader, B
Hoots, WK
Kisker, CT
Lusher, JM
Rosenfield, CG
Shapiro, AD
Smith, H
Taft, E
Citation: Ns. Key et al., Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors, THROMB HAEM, 80(6), 1998, pp. 912-918